logo
A Construction Crew Accidentally Uncovered the Remains of 100+ Horses

A Construction Crew Accidentally Uncovered the Remains of 100+ Horses

Yahoo28-04-2025

Crews working on a housing project in the Bad Cannstatt district of Stuttgart recently uncovered a second-century horse cemetery.
Archaeologists discovered over 100 skeletons of horses used by the Roman calvary.
The site was a known military stronghold for the Roman army.
A well-defined horse cemetery uncovered in Stuttgart's Bad Cannstatt neighborhood was the final resting place for over 100 horses that were part of the Roman Empire's cavalry in the second century A.D.
Construction crews discovered the cemetery during preparations for a housing project. Over time, excavations by the archaeological company ArchaeoBW—under the supervision of the State Office for Monument Preservation of the Stuttgart Regional Council—continued to unearth evidence from what is now believed to be the largest Roman-era horse cemetery in southern Germany, according to a translated statement from the council.
Considered one of the most important Roman military locations in modern-day southwestern Germany, experts believe the Roman calvary occupying the region had about 500 soldiers on site, and sustained a potential population of over 700 horses.
The first discovery of a horse skeleton in the area actually occurred in 1920 (also during a housing project), but the recent development uncovered the entire cemetery. Sara Roth, an archaeologist with the preservation office, said that radiocarbon dating helped pinpoint the age of the cemetery. 'Due to the archaeological and historical knowledge of the Roman Bad Cannstatt,' she said in a statement, 'the horses of the equestrian unit—a so-called ala—can be assigned, which was stationed on the Hallschlag from about 100 to 150 A.D.'
Roth said that the deceased horses were buried about 1,300 feet from the equestrian barns (about 650 feet from the soldier's quarters), and would have been constantly replaced. Evidence shows that the carcasses were slid into shallow pits and buried lying on their side with outstretched or bent legs. And even with the dense burials, there were few overlaps of graves, exposing that the site was likely clearly defined with above-ground markers. Even if a horse could walk on its own, if it was deemed beyond military usefulness, it would have been taken to the cemetery and killed there.
'The horses do not seem to have all died at the same time in a major event such as a battle or epidemic,' Roth said. 'Rather, here are the animals that either died during the presence of the ala in Bad Cannstatt due to illness, injury, or other reasons, or who no longer did their task as a military horse.'
One grave was of particular interest to archaeologists, as they discovered two jugs and a small oil lamp placed in the crook of the legs of one of the horses—grave goods typically reserved for humans. 'Here we see a particularly close connection of the owner to his horse,' Roth said. 'Even after about 1,800 years, the grief over the death of this one animal is still apparent.'
The crew also discovered the face-down skeleton of a human male—far from the regular burial location for the Roman settlement, he was likely a social outcast.
Experts plan to study the sex, age at death, and size of the horses while looking for possible diseases and causes of death. The team hopes to uncover more details about the Roman calvary.
You Might Also Like
The Do's and Don'ts of Using Painter's Tape
The Best Portable BBQ Grills for Cooking Anywhere
Can a Smart Watch Prolong Your Life?

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Ancient Romans snacked on deep-fried songbirds
Ancient Romans snacked on deep-fried songbirds

Yahoo

time3 hours ago

  • Yahoo

Ancient Romans snacked on deep-fried songbirds

Fast food didn't start with McDonald's—quick, convenient meals have been a dietary staple of busy societies for millennia. Across the Roman empire, roadside shops known as popinae and tabernae often served up inexpensive, affordable dishes to hungry locals and travelers alike. But after scouring ancient garbage piles near one such popina in Mallorca, Spain, archeologists are better understanding how certain entrées transcended class divisions more often than previously thought. According to findings recently published in the International Journal of Osteoarchaeology, Roman commoners frequently enjoyed dining on thrushes—small songbirds once thought to be a luxury dish. Birds were prominent figures in ancient Rome. Certain owls and eagles were considered powerful divinatory omens, while smaller avian species like thrushes were popular as both pets and meals. In the latter case, however, ancient texts suggest thrushes were primarily eaten by wealthier Romans. 'Classical sources frequently describe these small birds as a delicacy served in elite banquets, often prepared with elaborate culinary techniques,' the study's authors write. They also cite recipes documented by Pliny the Elder and Apicius that described fattening songbirds with figs before roasting and serving them with complex sauces. These assumptions were recently challenged by finds at an excavation in Mallorca, Spain. There, archeologists from the Mediterranean Institute for Advanced Studies (IMEDEA) uncovered a large cesspit beside a roadside popina snack bar. The building also featured six amphorae (large vats) embedded in its countertop in a configuration like the one seen in Pompeii's famous street food court, or thermopolia. Amid the refuse were 165 thrush bones alongside other common food remains like sea shells as well as fish and pig bones. The condition of the songbirds' broken bones suggest that they were flattened and cooked whole with oil in the amphorae. In addition to the thrushes, archeologists also documented remains from domesticated chickens and European rabbits. These point to a wider menu tailored to everyday customers. Taken altogether, it appears that thrushes were served up similar to today's sports bar chicken wings. The food shop in Mallorca isn't the only example of deep-fried songbirds across Rome. As Arkeonews notes, additional finds in Pompeii and Britain indicates a widespread culture of ancient Roman fast food. 'Thrushes, though a minor component of the Roman diet compared to livestock, represent an important facet of urban food consumption,' the study's authors conclude. 'Ultimately, this research highlights the need to move beyond elite-centric narratives and consider the diverse ways in which food practices shaped the lived experiences of ancient urban communities.'

Merck & Co (MRK) RSV Antibody for Infants Approved by US FDA
Merck & Co (MRK) RSV Antibody for Infants Approved by US FDA

Yahoo

time7 hours ago

  • Yahoo

Merck & Co (MRK) RSV Antibody for Infants Approved by US FDA

Merck & Co., Inc. (NYSE:MRK) is one of the . On June 9, Merck's preventative antibody shot received authorization from the U.S. Food and Drug Administration (FDA). This shot shields infants up to the age of one from the respiratory syncytial virus during their first RSV period. RSV refers to a common respiratory virus that leads to seasonal infections like the flu, yet for infants and older people, it is a primary cause of pneumonia and death. There has been limited availability of Sanofi's and AstraZeneca's preventive shots for RSV for the previously mentioned age group so far. Merck's antibody, called clesrovimab and sold under the name Enflonsia, can be taken as a single dose to protect healthy pre-term, full-term, and at-risk infants from mild to aggressive RSV. A close-up of a person's hand holding a bottle of pharmaceuticals. Merck & Co., Inc. (NYSE:MRK) projects Enflonsia shipments to turn up on schedule for the 2025-2026 RSV season. The CDC's Advisory Committee on Immunization Practices will likely gather later in June to assess and recommend the use of Enflonsia for infants. Merck is a global healthcare company that develops treatments for cancer, infectious diseases, and chronic conditions, and also provides vaccines and health solutions for both humans and animals. While we acknowledge the potential of MRK as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.

Axtria Ignite 2025: Defining Leadership in the Agentic AI Era for the Life Sciences Industry
Axtria Ignite 2025: Defining Leadership in the Agentic AI Era for the Life Sciences Industry

Yahoo

time10 hours ago

  • Yahoo

Axtria Ignite 2025: Defining Leadership in the Agentic AI Era for the Life Sciences Industry

Axtria Ignite 2025 Champions Life Sciences Innovation with a Focus on AI-driven transformations, Patient-Centricity, and Next-Generation Therapies Honoring Excellence: Ignite Leadership Awards Celebrate Trailblazing Industry Leaders Driving Impact and Paving the Path for the Industry Breakthrough Dialogues: 25 Impactful Sessions Spotlight the Convergence of AI, Data, and Therapeutic Innovation in the Agentic Era BERKELEY HEIGHTS, N.J., June 11, 2025 /PRNewswire/ -- Axtria Inc., an AI-first data analytics company empowering the life sciences industry, successfully hosted Axtria Ignite 2025, its flagship annual conference that brought together over 400 senior industry leaders, innovators, and changemakers on June 4-5 in Princeton, N.J. "The life sciences industry stands at the crossroads of unprecedented transformation. At Axtria Ignite 2025, we didn't just talk about what's possible; we explored what's next. From Agentic AI to patient-centric strategies, we are proud to lead this conversation and enable our clients to drive change at speed and scale," said Jaswinder Chadha, President and CEO of Axtria. "This year's event reflects our deep commitment to shaping a more intelligent, agile, and impactful future for healthcare." Axtria Ignite 2025 spotlighted three transformative themes in life sciences: new commercialization strategies for next-gen therapies like rare, orphan, cell, and gene treatments; keeping patients at the heart of operations to drive meaningful impact; and the rapid shift toward GenAI and Agentic AI, with real-world case studies revealing both successes and lessons learned. The conference featured several sessions that were a mix of presentations, panels, workshops, and roundtables, with over 50 speakers from the world's top life sciences companies. It included demo stations for the latest Agentic Innovations in Axtria's products and evening receptions that sprinkled some fun along with networking. Axtria also recognized outstanding industry leadership through its annual Ignite Leadership Award. This year's honorees were Greg Meyers, EVP and Chief Digital and Technology Officer, Bristol Myers Squibb; Ritesh Mehra, Chief Financial Officer, Ferring Pharmaceuticals U.S.; Madhavi Ramakrishna, Senior Vice President of Enterprise AI and Chief Digital and Technology Officer for Commercial, GSK; Stephanie Odutola, Executive Director of U.S. Sales Force Operations, AstraZeneca; and Vikram Singh, Vice President and Global Head of Commercial IT Data Analytics and DSAI, Novartis. For more information about how Axtria can support your organization's Agentic AI journey, please visit About Axtria's Products and Solutions Axtria is proud to work with 16 of the top 20 life sciences companies globally. From our roots as a trusted consultant to our status as one of the world's leading providers of cloud-based pharmaceutical management software, Axtria powers digital transformations in life sciences. Our experts call upon years of domain experience in the industry to guide pharma giants from brand launches to retirement. Our products go even further. Axtria is our agentic platform, featuring more than 30 agents, apps, and APIs, along with a full experimentation environment to find the perfect solution for unique business challenges. Axtria SalesIQ™ helps optimize field forces and provider engagements. Axtria CustomerIQ™ leverages AI-enabled next-best-action omnichannel choices. Axtria MarketingIQ™ turns investment analyses into pinpoint strategies. And Axtria DataMAx™ and DataMAx™ for Emerging Pharma is the data management framework that pulls it all together with best-in-class security and integration. About Axtria Axtria helps life sciences companies harness the potential of data science and software to improve patient outcomes by connecting the right therapies to the right patients at the right time. The company is a leading global provider of award-winning cloud software and data analytics to the life sciences industry. We're proud to deliver proven solutions that help pharmaceutical, medical device, and diagnostics companies complete their journey from data to insights to action, enabling them to earn superior returns on their investments. As a participant in the United Nations Global Compact, Axtria is committed to aligning strategies and operations with universal principles on human rights, labor, environment, and anti-corruption, and taking actions that advance societal goals. For more information, please visit View original content to download multimedia: SOURCE Axtria, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store